  Objective: Deep Learning-based Radiomics (DLR) has achieved great success in
medical image analysis and has been considered a replacement for conventional
radiomics that relies on handcrafted features. In this study, we aimed to
explore the capability of DLR for the prediction of 5-year Progression-Free
Survival (PFS) in Nasopharyngeal Carcinoma (NPC) using pretreatment PET/CT.
Methods: A total of 257 patients (170/87 in internal/external cohorts) with
advanced NPC (TNM stage III or IVa) were enrolled. We developed an end-to-end
multi-modality DLR model, in which a 3D convolutional neural network was
optimized to extract deep features from pretreatment PET/CT images and predict
the probability of 5-year PFS. TNM stage, as a high-level clinical feature,
could be integrated into our DLR model to further improve the prognostic
performance. To compare conventional radiomics and DLR, 1456 handcrafted
features were extracted, and optimal conventional radiomics methods were
selected from 54 cross-combinations of 6 feature selection methods and 9
classification methods. In addition, risk group stratification was performed
with clinical signature, conventional radiomics signature, and DLR signature.
Results: Our multi-modality DLR model using both PET and CT achieved higher
prognostic performance than the optimal conventional radiomics method.
Furthermore, the multi-modality DLR model outperformed single-modality DLR
models using only PET or only CT. For risk group stratification, the
conventional radiomics signature and DLR signature enabled significant
differences between the high- and low-risk patient groups in both internal and
external cohorts, while the clinical signature failed in the external cohort.
Conclusion: Our study identified potential prognostic tools for survival
prediction in advanced NPC, suggesting that DLR could provide complementary
values to the current TNM staging.
